This article is more than 5 years old. Information may no longer be current.

Akorn shareholders approve Fresenius Kabi merger

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Akorn shareholders have approved a merger with Fresenius Kabi, according to an Akorn press release.

Fresenius Kabi announced in April that it would acquire the company for $4.3 billion, or $34 per share. The agreement allowed for $450 million in debt to be assumed in the transaction, which is expected to close by early 2018.

The deal is still subject to regulatory approvals and customary closing conditions, the release said.